Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Clinical trial NCT01968733 · COMPLETED

Trial details

NCT number: NCT01968733
Sponsor: Melinta Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Community-acquired Bacterial Pneumonia

Start date: 2013-11-01
Primary completion: 2015-07-01
Enrollment: 863

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.